HUTCHMED CHINA-ADR (HCM:NASDAQ)

$10.96 0.28 (2.6217%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed HUTCHMED CHINA-ADR (HCM:NASDAQ) News Sources

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026

09-04-2026

yahoo.com

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026

23-04-2026

yahoo.com

HUTCHMED Highlights $1.4B Liquidity, 2026 Revenue Outlook, and SAFFRON Catalyst at DB Conference

29-04-2026

marketbeat.com

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

29-04-2026

yahoo.com

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

29-04-2026

yahoo.com

HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

21-05-2026

yahoo.com

Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

21-05-2026

yahoo.com

HSBC CEO Pitches Hong Kong Clients, Hires More Bankers After Setbacks

31-05-2026

yahoo.com

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating

02-06-2026

yahoo.com

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

12-06-2026

yahoo.com

HUTCHMED CHINA-ADR (HCM:NASDAQ) Sentiment Trend

0 25 50 75 100 77 54 87 61 56 78 81 53 92 79 09-04-2026 23-04-2026 29-04-2026 21-05-2026 31-05-2026 02-06-2026 12-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

HUTCHMED CHINA-ADR (HCM:NASDAQ) FAQs

toggle

What is the current price of HUTCHMED CHINA-ADR (HCM:NASDAQ)?

The current price of HUTCHMED CHINA-ADR (HCM:NASDAQ) is $10.96.


toggle

HUTCHMED CHINA-ADR (HCM:NASDAQ) absolute price change since previous trading day?

The absolute price change of HUTCHMED CHINA-ADR (HCM:NASDAQ) since the previous trading day is $0.28.


toggle

HUTCHMED CHINA-ADR (HCM:NASDAQ) percentage price change since previous trading day?

The percentage price change of HUTCHMED CHINA-ADR (HCM:NASDAQ) since the previous trading day is 2.6217%.


toggle

What is the most recent average sentiment score for HUTCHMED CHINA-ADR (HCM:NASDAQ)?

The most recent average sentiment score for HUTCHMED CHINA-ADR (HCM:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for HUTCHMED CHINA-ADR (HCM:NASDAQ)?

The most recent sentiment for HUTCHMED CHINA-ADR (HCM:NASDAQ) is .


SEC-8K** Filing Available For HUTCHMED CHINA-ADR (HCM:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.